Merck earnings, Revenue beat in Q2

  • Investing.com
Merck earnings, Revenue beat in Q2
Credit: © Reuters.

Investing.com - Merck (NS: PROR ) reported on Friday second quarter earnings that beat analysts' forecasts and revenue that topped expectations.

Merck announced earnings per share of €2.64 on revenue of €5.57B. Analysts polled by Investing.com anticipated EPS of €2.51 on revenue of €5.42B.

Merck shares are down 26.38% from the beginning of the year and are trading at €172.69 , down-from-52-week-high.They are under-performing the EUR/USD which is down 0% year to date.

Merck follows other major Healthcare sector earnings this month

Merck's report follows an earnings beat by Elekta B on Thursday, August 25, 2022, who reported EPS of €0.16 on revenue of €3.33B, compared to forecasts EPS of €0.1585 on revenue of €3.33B.

Stay up-to-date on all of the upcoming earnings reports by visiting Investing.com's earnings calendar

Drop an image here or Supported formats: *.jpg, *.png, *.gif up to 5mb

Error: File type not supported

Drop an image here or

100

Related Articles